A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing […]
MD Anderson and Mirati Therapeutics collaborate to expand evaluation of potent KRAS inhibitors
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration […]
Sanofi’s digital strategy prioritizes clinical trials, therapeutics, diabetes
Women In Health ITResource Center Stay Informed Susbscribe today to receive our FREE monthly e-newsletter Have valuable and interesting information […]